Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs Innate Pharma S.A. Sponsored ADR (IPHA)

Canton Strategic Holdings, Inc. and Innate Pharma S.A. Sponsored ADR are both Biotechnology companies. Canton Strategic Holdings, Inc. and Innate Pharma S.A. Sponsored ADR are of similar size ($164.1M and $160.9M). Canton Strategic Holdings, Inc. has the higher net margin (0.00% vs −99.7%) and the lower return on invested capital (−8.11% vs 0.00%). Across the 10 metrics below, Innate Pharma S.A. Sponsored ADR leads on 6 and Canton Strategic Holdings, Inc. on 4.

Valuation

Metric CNTN IPHA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.98 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.12 9.02
Earnings yield (44.30%) (81.01%) (32.88%)
Free cash flow yield (4.96%) 0.00% (23.13%)

Profitability

Metric CNTN IPHA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (99.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (43.10%) 0.00% (51.96%)
Return on assets (34.60%) 0.00% (46.06%)
Return on invested capital (8.11%) 0.00% 0.00%

Growth

Metric CNTN IPHA Biotechnology median
Revenue growth (TTM) — (4.17%) 6.76%
EPS growth (last fiscal year) 88.10% 6.06% 29.88%
Revenue growth, 5-year CAGR — (33.86%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN IPHA Biotechnology median
Debt to equity 0.00 (0.50) 0.00
Current ratio 15.70 0.60 4.97
Net debt to EBITDA 0.85 0.22 1.01

Dividend

Metric CNTN IPHA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTN IPHA Biotechnology median
Market cap 164.14m 160.85m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack